Paul Sieber

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

Matthew R. Smith, Fred Saad, Robert E. Coleman et al. · The Lancet · 2011 · 792 citations · Full text

Urology, Oncology, Genitourinary Cancer +6

A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer

Dipen J. Parekh, Sanoj Punnen, Daniel D. Sjoberg et al. · European Urology · 2014 · 402 citations

Usa Confirms, Urology, Cancer Epidemiology +9

Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time

Matthew R. Smith, Fred Saad, Stéphane Oudard et al. · Journal of Clinical Oncology · 2013 · 247 citations · Full text

Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer

Alison Stopeck, Karim Fizazi, Jean-Jacques Body et al. · Supportive Care in Cancer · 2015 · 187 citations · Full text

Sarcopenia During Androgen-Deprivation Therapy for Prostate Cancer

Matthew R. Smith, Fred Saad, Blair Egerdie et al. · Journal of Clinical Oncology · 2012 · 186 citations · Full text